Glycated hemoglobin measurements at three, 12 and 24 months postpartum after gestational diabetes.
Clin Invest Med
; 42(4): E37-E41, 2019 12 29.
Article
em En
| MEDLINE
| ID: mdl-31922707
ABSTRACT
PURPOSE:
To determine the associations between glycated hemoglobin (A1C) values at three, 12 and 24 months postpartum taken during the Families Defeating Diabetes trial.METHODS:
The Families Defeating Diabetes trial was a randomized 12 month lifestyle intervention delivered in the first year postpartum. Women were reviewed at three, 6 12 and 24 months for body habitus, diet and lifestyle choices. Glycated hemoglobin levels were measured at three, 12 and 24 months.RESULTS:
There were 170 randomizationparticipants:
89 interventional (INT); and 81 control (CON). Of these 170 participants, 50 INT and 47 CON completed 12-month follow-up and 26 INT and 24 CON completed 24-month follow-up. Study outcomes did not differ between the cohorts. Combined intraclass correlation coefficients for reliability of repeated results showed substantial reliability 0.74 (95% CI 0.63, 0.83) between three and 12 month A1C; and 0.72 (95% CI 0.51, 0.85) for three and 24 month A1C. Pearson correlations for three month vs 12 month A1C were r=0.745 (p.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Hemoglobinas Glicadas
/
Diabetes Gestacional
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
Limite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Clin Invest Med
Ano de publicação:
2019
Tipo de documento:
Article